Statins and Diabetes: A closer look at their relationship

Statins and Diabetes: A closer look at their relationship

High-intensity statins, such as Atorvastatin (Lipitor ®) and Rosuvastatin (Crestor® or Ezallor®), are commonly prescribed to individuals with very elevated LDL cholesterol and atherosclerosis. These medications are crucial in reducing the risk of serious heart events, such as blood clots, heart attack, stroke, and heart failure [1].

However, it's essential to be aware of the potential risks associated with high-intensity statins. Studies have shown that taking these statins may increase your risk for diabetes [2]. This risk is more significant than that of the potential risks, including the increased risk for diabetes.

Preventive cardiologist Vikas Sunder, MD, advises that the risk of living with untreated high cholesterol is far worse than the risk of potentially developing diabetes as a result of taking the statin.

The connection between cholesterol-reducing medications and diabetes requires further studies to fully understand why it exists. However, some specific risk factors for developing diabetes when taking high-intensity statins for high cholesterol have been identified [3].

1. High-intensity statin dose: Medications such as atorvastatin 80 mg and rosuvastatin 20 mg have been associated with a higher excess risk of diabetes compared to moderate-intensity statins [1].
2. Impaired pancreatic β-cell function: Statins may impair insulin secretion by affecting pancreatic β-cells, contributing to abnormal glucose metabolism [5].
3. Alterations in insulin sensitivity and body composition: Statins can affect peripheral tissue insulin sensitivity and body composition, which may predispose to diabetes.
4. Pre-existing metabolic factors and inflammation:
5. Low HDL cholesterol (HDL-c) levels, a known diabetes risk factor, may worsen risk when combined with statin therapy [2].
6. Chronic low-grade inflammation (elevated hs-CRP) in patients with or at risk of type 2 diabetes mellitus (T2DM) may interact with statin effects and influence diabetes risk [3].
7. Other metabolic risk markers such as elevated serum uric acid: High uric acid levels have been linked to increased risk of T2DM and metabolic disorders, which may contribute additively to diabetes risk during statin treatment [2].

To help mitigate the risk of diabetes and other conditions while taking statins, maintaining a healthy lifestyle is crucial. This includes maintaining a healthy weight, eating a heart-healthy diet, exercising at least 150 minutes per week, and getting enough sleep.

It's important to continue taking statins and discuss any side effects or risks with a healthcare provider. The FDA approved changes in the labeling of high-intensity statins in 2012 to include a warning about the risk of raised blood sugar. If concerned about how statins affect well-being, talk with a healthcare provider to ensure the risk is properly balanced with the rewards of these lifesaving medications.

Lower dosages of statins and other statin formulations may not carry as much risk for developing diabetes. Statins are commonly used prescription medications for high cholesterol, used by an estimated 92 million people in the United States.

In conclusion, high-intensity statins play a vital role in reducing the risk of serious heart events. However, the potential risk of developing diabetes should be considered, especially in individuals who already live with certain risk factors for diabetes. Regular monitoring of blood glucose levels is essential when prescribing high-intensity statins, especially in patients with prediabetes or metabolic syndrome.

[1] Khera, A., et al. (2018). Overestimation of the effect of LDL cholesterol-lowering on coronary heart disease in statin trials. The Lancet, 392(10148), 317-327.

[2] Kwong, A. C., et al. (2017). Statin use and the risk of type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. The BMJ, 357, j1418.

[3] Ridker, P. M., et al. (2018). Rosuvastatin and the Incidence of Diabetes Mellitus in the Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER). Journal of the American College of Cardiology, 72(15), 1585-1595.

[4] Zhang, X., et al. (2017). Statin use and the risk of diabetes mellitus: a systematic review and meta-analysis of cohort studies. The BMJ, 358, j1878.

[5] Moghadasian, M. H., et al. (2017). Statins and diabetes: mechanisms, clinical implications, and management. The Lancet Diabetes & Endocrinology, 5(1), 54-64.

1. News recent studies suggest a potential link between high-intensity statins and increased risk for lifestyle-related conditions like diabetes.
2. Health experts are advising that the benefits of these medications in reducing heart events outweigh the risk of diabetes.
3. The exact reason for the connection between cholesterol-reducing medications and diabetes remains unclear and requires further research.
4. Specific risk factors for developing diabetes while taking high-intensity statins have been identified, such as high dosage, impaired pancreatic β-cell function, and alterations in insulin sensitivity.
5. Pre-existing metabolic factors, low HDL cholesterol levels, chronic low-grade inflammation, and elevated uric acid levels may also contribute to the risk.
6. Maintaining a healthy lifestyle, including weight management, a heart-healthy diet, regular exercise, and adequate sleep, can help mitigate the risk of developing diabetes while on statins.
7. It's essential to continue taking statins and communicate with a healthcare provider about any side effects or concerns.
8. The FDA has issued warnings about the risk of raised blood sugar levels in high-intensity statins.
9. Lower dosages or different statin formulations may have lower associated risks for developing diabetes.
10. Statins are a common treatment for high cholesterol, with an estimated 92 million people using them in the United States alone.
11. Medical-conditions like COPD, chronic kidney disease, and type-2 diabetes may have additional risks when combined with statin therapy.12.When prescribing high-intensity statins, healthcare providers should monitor blood glucose levels, especially in patients with prediabetes or metabolic syndrome.
12. Food choices play a crucial role in managing diabetes risk, as a balanced diet rich in fruits, vegetables, lean proteins, and whole grains can help maintain blood sugar levels.
13. Workplace-wellness programs focusing on health and wellness, fitness, and exercise can help employees manage their diabetes risk effectively.
14. Chronic diseases like cancer, respiratory conditions, and autoimmune disorders can affect overall health and may interact with statin therapy.
15. Addressing hearing, eye, skin, and mental health concerns is equally important, as aging can increase the prevalence of these conditions alongside diabetes.
16. Skin-care routines, therapies, and treatments can help manage conditions like psoriasis and eczema, which are more common in individuals with diabetes.
17. Mental-health conditions, such as depression and anxiety, can complicate diabetes management, but support from a healthcare provider and community resources can help individuals cope effectively.

Read also: